| Ident. | Authors (with country if any) | Title |
|---|
| 000018 (2020) |
Zhengpin Wang [États-Unis] ; Xiaojiang Xu [États-Unis] | scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for SARS-CoV-2 Infection in Spermatogonia, Leydig and Sertoli Cells. |
| 000083 (2020) |
Xiao-Li Qiang ; Peng Xu ; Gang Fang ; Wen-Bin Liu ; Zheng Kou | Using the spike protein feature to predict infection risk and monitor the evolutionary dynamic of coronavirus |
| 000108 (2020) |
David Cyranoski | This scientist hopes to test coronavirus drugs on animals in locked-down Wuhan. |
| 000472 (2020) |
Jiahua He [République populaire de Chine] ; Huanyu Tao [République populaire de Chine] ; Yumeng Yan [République populaire de Chine] ; Sheng-You Huang [République populaire de Chine] ; Yi Xiao [République populaire de Chine] | Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2. |
| 000509 (2020) |
Zaid Abassi [Israël] ; Suheir Assady [Israël] ; Emad E. Khoury [Israël] ; Samuel N. Heyman [Israël] | Letter to the Editor: Angiotensin-converting enzyme 2: an ally or a Trojan horse? Implications to SARS-CoV-2-related cardiovascular complications. |
| 000512 (2020) |
Sarah E. Henrickson [États-Unis] | Learning from our immunological history: What can SARS-CoV teach us about SARS-CoV-2? |
| 000560 (2020) |
Claudia Cava [Italie] ; Gloria Bertoli [Italie] ; Isabella Castiglioni [Italie] | In Silico Discovery of Candidate Drugs against Covid-19. |
| 000619 (2020) |
Michael Letko [États-Unis] ; Andrea Marzi [États-Unis] ; Vincent Munster [États-Unis] | Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. |
| 000749 (2020) |
Daniel Wrapp [États-Unis] ; Nianshuang Wang [États-Unis] ; Kizzmekia S. Corbett [États-Unis] ; Jory A. Goldsmith [États-Unis] ; Ching-Lin Hsieh [États-Unis] ; Olubukola Abiona [États-Unis] ; Barney S. Graham [États-Unis] ; Jason S. Mclellan [États-Unis] | Cryo-EM structure of the 2019-nCoV spike in the prefusion
conformation |
| 000853 (2020) |
Xiuyuan Ou [République populaire de Chine] ; Yan Liu [République populaire de Chine] ; Xiaobo Lei [République populaire de Chine] ; Pei Li [République populaire de Chine] ; Dan Mi [République populaire de Chine] ; Lili Ren [République populaire de Chine] ; Li Guo [République populaire de Chine] ; Ruixuan Guo [République populaire de Chine] ; Ting Chen [République populaire de Chine] ; Jiaxin Hu [République populaire de Chine] ; Zichun Xiang [République populaire de Chine] ; Zhixia Mu [République populaire de Chine] ; Xing Chen [République populaire de Chine] ; Jieyong Chen [République populaire de Chine] ; Keping Hu [République populaire de Chine] ; Qi Jin [République populaire de Chine] ; Jianwei Wang [République populaire de Chine] ; Zhaohui Qian [République populaire de Chine] | Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV |
| 000889 (2020) |
Kamal Kant Sahu [Oman] ; Ajay Kumar Mishra [Oman] ; Amos Lal [Oman] | COVID-2019: update on epidemiology, disease spread and management. |
| 000913 (2020) |
Andrew M. South [États-Unis] ; Debra I. Diz [États-Unis] ; Mark C. Chappell [États-Unis] | COVID-19, ACE2, and the cardiovascular consequences. |
| 000923 (2020) |
Paola Rizzo [Italie] ; Francesco Vieceli Dalla Sega [Italie] ; Francesca Fortini [Italie] ; Luisa Marracino [Italie] ; Claudio Rapezzi [Italie] ; Roberto Ferrari [Italie] | COVID-19 in the heart and the lungs: could we “Notch” the inflammatory storm? |
| 000A16 (2020) |
Rhian M. Touyz [Royaume-Uni] ; Hongliang Li [République populaire de Chine] ; Christian Delles [Royaume-Uni] | ACE2 the Janus-faced protein - from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19. |
| 000A28 (2020) |
Peng Zhou [République populaire de Chine] ; Xing-Lou Yang [République populaire de Chine] ; Xian-Guang Wang [République populaire de Chine] ; Ben Hu [République populaire de Chine] ; Lei Zhang [République populaire de Chine] ; Wei Zhang [République populaire de Chine] ; Hao-Rui Si [République populaire de Chine] ; Yan Zhu [République populaire de Chine] ; Bei Li [République populaire de Chine] ; Chao-Lin Huang [République populaire de Chine] ; Hui-Dong Chen [République populaire de Chine] ; Jing Chen [République populaire de Chine] ; Yun Luo [République populaire de Chine] ; Hua Guo [République populaire de Chine] ; Ren-Di Jiang [République populaire de Chine] ; Mei-Qin Liu [République populaire de Chine] ; Ying Chen [République populaire de Chine] ; Xu-Rui Shen [République populaire de Chine] ; Xi Wang [République populaire de Chine] ; Xiao-Shuang Zheng [République populaire de Chine] ; Kai Zhao [République populaire de Chine] ; Quan-Jiao Chen [République populaire de Chine] ; Fei Deng [République populaire de Chine] ; Lin-Lin Liu [République populaire de Chine] ; Bing Yan [République populaire de Chine] ; Fa-Xian Zhan [République populaire de Chine] ; Yan-Yi Wang [République populaire de Chine] ; Geng-Fu Xiao [République populaire de Chine] ; Zheng-Li Shi [République populaire de Chine] | A pneumonia outbreak associated with a new coronavirus of probable bat origin |
| 000D00 (2018) |
Wenfei Song [République populaire de Chine] ; Miao Gui [République populaire de Chine] ; Xinquan Wang [République populaire de Chine] ; Ye Xiang [République populaire de Chine] | Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. |
| 000F36 (2016) |
Yvonne Ting-Chun Yu [Taïwan] ; Ssu-Chia Chien [Taïwan] ; I-Yin Chen [Taïwan] ; Chia-Tsen Lai [Taïwan] ; Yeou-Guang Tsay [Taïwan] ; Shin C. Chang [Taïwan] ; Ming-Fu Chang [Taïwan] | Surface vimentin is critical for the cell entry of SARS-CoV |
| 000F58 (2016) |
Hongpeng Jia [États-Unis] | Pulmonary Angiotensin-Converting Enzyme 2 (ACE2) and Inflammatory Lung Disease. |
| 001263 (2015) |
Natalia T. Freund [Israël, États-Unis] ; Anna Roitburd-Berman [Israël] ; Jianhua Sui [États-Unis, République populaire de Chine] ; Wayne A. Marasco [États-Unis] ; Jonathan M. Gershoni [Israël] | Reconstitution of the receptor-binding motif of the SARS coronavirus |
| 001292 (2015) |
Xing-Lou Yang [République populaire de Chine] ; Ben Hu [République populaire de Chine] ; Bo Wang [République populaire de Chine] ; Mei-Niang Wang [République populaire de Chine] ; Qian Zhang [République populaire de Chine] ; Wei Zhang [République populaire de Chine] ; Li-Jun Wu [République populaire de Chine] ; Xing-Yi Ge [République populaire de Chine] ; Yun-Zhi Zhang [République populaire de Chine] ; Peter Daszak [États-Unis] ; Lin-Fa Wang [Singapour] ; Zheng-Li Shi [République populaire de Chine] | Isolation and Characterization of a Novel Bat Coronavirus Closely Related to the Direct Progenitor of Severe Acute Respiratory Syndrome Coronavirus. |
| 001298 (2015) |
Xuesen Zhao [États-Unis] ; Fang Guo [États-Unis] ; Mary Ann Comunale [États-Unis] ; Anand Mehta [États-Unis] ; Mohit Sehgal [États-Unis] ; Pooja Jain [États-Unis] ; Andrea Cuconati [États-Unis] ; Hanxin Lin [Canada] ; Timothy M. Block [États-Unis] ; Jinhong Chang [États-Unis] ; Ju-Tao Guo [États-Unis] | Inhibition of endoplasmic reticulum-resident glucosidases impairs severe acute respiratory syndrome coronavirus and human coronavirus NL63 spike protein-mediated entry by altering the glycan processing of angiotensin I-converting enzyme 2. |
| 001554 (2014) |
Adeline Heurich [Allemagne] ; Heike Hofmann-Winkler ; Stefanie Gierer ; Thomas Liepold ; Olaf Jahn ; Stefan Pöhlmann | TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. |
| 001638 (2014) |
Aleksandra Milewska [Pologne] ; Miroslaw Zarebski [Pologne] ; Paulina Nowak [Pologne] ; Karol Stozek [Pologne] ; Jan Potempa [États-Unis] ; Krzysztof Pyrc [Pologne] | Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells. |
| 001656 (2014) |
Jianhua Sui [États-Unis] ; Meagan Deming [États-Unis] ; Barry Rockx [États-Unis] ; Robert C. Liddington [États-Unis] ; Quan Karen Zhu [États-Unis] ; Ralph S. Baric [États-Unis] ; Wayne A. Marasco [États-Unis] | Effects of Human Anti-Spike Protein Receptor Binding Domain Antibodies on Severe Acute Respiratory Syndrome Coronavirus Neutralization Escape and Fitness |
| 001704 (2014) |
Sheng-Fan Wang [Taïwan] ; Sung-Pin Tseng [Taïwan] ; Chia-Hung Yen [Taïwan] ; Jyh-Yuan Yang [Taïwan] ; Ching-Han Tsao [Taïwan] ; Chun-Wei Shen [Taïwan] ; Kuan-Hsuan Chen [Taïwan] ; Fu-Tong Liu [Taïwan] ; Wu-Tse Liu [Taïwan] ; Yi-Ming Arthur Chen [Taïwan] ; Jason C. Huang [Taïwan] | Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins. |
| 001830 (2013) |
Jose A. Regla-Nava [Espagne] ; Jose M. Jimenez-Guarde O [Espagne] ; Jose L. Nieto-Torres [Espagne] ; Thomas M. Gallagher [États-Unis] ; Luis Enjuanes [Espagne] ; Marta L. Dediego [Espagne] | The replication of a mouse adapted SARS-CoV in a mouse cell line stably expressing the murine SARS-CoV receptor mACE2 efficiently induces the expression of proinflammatory cytokines |
| 001874 (2013) |
Fang Li | Receptor recognition and cross-species infections of SARS coronavirus |
| 001880 (2013) |
Graham Simmons [États-Unis] ; Pawel Zmora ; Stefanie Gierer ; Adeline Heurich ; Stefan Pöhlmann | Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research. |
| 001890 (2013) |
Adeyemi O. Adedeji [États-Unis] ; William Severson ; Colleen Jonsson ; Kamalendra Singh ; Susan R. Weiss ; Stefan G. Sarafianos | Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms. |
| 001908 (2013) |
Xing-Yi Ge ; Jia-Lu Li ; Xing-Lou Yang ; Aleksei A. Chmura ; Guangjian Zhu ; Jonathan H. Epstein ; Jonna K. Mazet ; Ben Hu ; Wei Zhang ; Cheng Peng ; Yu-Ji Zhang ; Chu-Ming Luo ; Bing Tan ; Ning Wang ; Yan Zhu ; Gary Crameri ; Shu-Yi Zhang ; Lin-Fa Wang ; Peter Daszak ; Zheng-Li Shi | Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. |
| 001910 (2013) |
Zhaohui Qian [États-Unis] ; Emily A. Travanty ; Lauren Oko ; Karen Edeen ; Andrew Berglund ; Jieru Wang ; Yoko Ito ; Kathryn V. Holmes ; Robert J. Mason | Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus. |
| 001958 (2013) |
Markus Hoffmann [Allemagne] ; Marcel Alexander Müller ; Jan Felix Drexler ; Jörg Glende ; Meike Erdt ; Tim Gützkow ; Christoph Losemann ; Tabea Binger ; Hongkui Deng ; Christel Schwegmann-We Els ; Karl-Heinz Esser ; Christian Drosten ; Georg Herrler | Differential sensitivity of bat cells to infection by enveloped RNA viruses: coronaviruses, paramyxoviruses, filoviruses, and influenza viruses. |
| 001983 (2013) |
Manli Wang ; Zhihong Hu | Bats as animal reservoirs for the SARS coronavirus: Hypothesis proved after 10 years of virus hunting |
| 001998 (2013) |
Thomas Perlot [Autriche] ; Josef M. Penninger | ACE2 - from the renin-angiotensin system to gut microbiota and malnutrition. |
| 001C66 (2012) |
M. Jaume [République populaire de Chine] ; M S Yip ; Y W Kam ; C Y Cheung ; F. Kien ; A. Roberts ; P H Li ; I. Dutry ; N. Escriou ; M. Daeron ; R. Bruzzone ; K. Subbarao ; J S M. Peiris ; B. Nal ; R. Altmeyer | SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement. |
| 001C73 (2012) |
Ronald Dijkman [Pays-Bas] ; Maarten F. Jebbink [Pays-Bas] ; Martin Deijs [Pays-Bas] ; Aleksandra Milewska [Pays-Bas] ; Krzysztof Pyrc [Pologne] ; Elena Buelow [Pays-Bas] ; Anna Van Der Bijl [Pays-Bas] ; Lia Van Der Hoek [Pays-Bas] | Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63. |
| 001C96 (2012) |
Kailang Wu ; Guiqing Peng ; Matthew Wilken ; Robert J. Geraghty [États-Unis] ; Fang Li | Mechanisms of Host Receptor Adaptation by Severe Acute Respiratory
Syndrome Coronavirus* |
| 001D02 (2012) |
Stephanie Bertram [Allemagne] ; Adeline Heurich [Allemagne] ; Hayley Lavender [Royaume-Uni] ; Stefanie Gierer [Allemagne] ; Simon Danisch [Allemagne] ; Paula Perin [Allemagne] ; Jared M. Lucas [États-Unis] ; Peter S. Nelson [États-Unis] ; Stefan Pöhlmann [Allemagne] ; Elizabeth J. Soilleux [Royaume-Uni] | Influenza and SARS-Coronavirus Activating Proteases TMPRSS2 and HAT Are Expressed at Multiple Sites in Human Respiratory and Gastrointestinal Tracts |
| 001D14 (2012) |
Marcel A. Müller ; V. Stalin Raj ; Doreen Muth ; Benjamin Meyer ; Stephan Kallies ; Saskia L. Smits ; Robert Wollny ; Theo M. Bestebroer ; Sabine Specht ; Tasnim Suliman ; Katrin Zimmermann ; Tabea Binger ; Isabella Eckerle ; Marco Tschapka ; Ali M. Zaki ; Albert D. M. E. Osterhaus ; Ron A. M. Fouchier ; Bart L. Haagmans ; Christian Drosten | Human Coronavirus EMC Does Not Require the SARS-Coronavirus Receptor and Maintains Broad Replicative Capability in Mammalian Cell Lines |
| 001D52 (2012) |
K K B. Li [République populaire de Chine] ; C W Yip ; C C Hon ; C Y Lam ; F. Zeng ; F C C. Leung | Characterisation of animal angiotensin-converting enzyme 2 receptors and use of pseudotyped virus to correlate receptor binding with susceptibility of SARS-CoV infection. |
| 001F86 (2012) |
Ann Demogines [États-Unis] ; Michael Farzan [États-Unis] ; Sara L. Sawyer [États-Unis] | Evidence for ACE2-Utilizing Coronaviruses (CoVs) Related to Severe Acute Respiratory Syndrome CoV in Bats |
| 001F95 (2012) |
Anna-Winona Struck [Allemagne] ; Marco Axmann [Allemagne] ; Susanne Pfefferle [Allemagne] ; Christian Drosten [Allemagne] ; Bernd Meyer [Allemagne] | A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2 |
| 002157 (2011) |
Ana Shulla [États-Unis] ; Taylor Heald-Sargent ; Gitanjali Subramanya ; Jincun Zhao ; Stanley Perlman ; Tom Gallagher | A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. |
| 002161 (2011) |
Kailang Wu [États-Unis] ; Lang Chen [États-Unis] ; Guiqing Peng [États-Unis] ; Wenbo Zhou [États-Unis] ; Christopher A. Pennell [États-Unis] ; Louis M. Mansky [États-Unis] ; Robert J. Geraghty [États-Unis] ; Fang Li [États-Unis] | A Virus-Binding Hot Spot on Human Angiotensin-Converting Enzyme 2 Is Critical for Binding of Two Different Coronaviruses▿ |
| 002411 (2010) |
I-Yin Chen [Taïwan] ; Shin C. Chang ; Hung-Yi Wu ; Ting-Chun Yu ; Wen-Chin Wei ; Shiming Lin ; Chung-Liang Chien ; Ming-Fu Chang | Upregulation of the chemokine (C-C motif) ligand 2 via a severe acute respiratory syndrome coronavirus spike-ACE2 signaling pathway. |
| 002431 (2010) |
Shiori Haga [Japon] ; Noriyo Nagata ; Tadashi Okamura ; Norio Yamamoto ; Tetsutaro Sata ; Naoki Yamamoto ; Takehiko Sasazuki ; Yukihito Ishizaka | TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds. |
| 002526 (2010) |
Meng Yu [Australie] ; Mary Tachedjian ; Gary Crameri ; Zhengli Shi ; Lin-Fa Wang | Identification of key amino acid residues required for horseshoe bat angiotensin-I converting enzyme 2 to function as a receptor for severe acute respiratory syndrome coronavirus. |
| 002548 (2010) |
Shutoku Matsuyama [Japon] ; Noriyo Nagata ; Kazuya Shirato ; Miyuki Kawase ; Makoto Takeda ; Fumihiro Taguchi | Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. |
| 002555 (2010) |
Ilona Glowacka [Allemagne] ; Stephanie Bertram ; Petra Herzog ; Susanne Pfefferle ; Imke Steffen ; Marcus O. Muench ; Graham Simmons ; Heike Hofmann ; Thomas Kuri ; Friedemann Weber ; Jutta Eichler ; Christian Drosten ; Stefan Pöhlmann | Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63. |
| 002881 (2010) |
Yuxuan Hou [République populaire de Chine] ; Cheng Peng [République populaire de Chine] ; Meng Yu [Australie] ; Yan Li [République populaire de Chine] ; Zhenggang Han [République populaire de Chine] ; Fang Li [États-Unis] ; Lin-Fa Wang [Australie] ; Zhengli Shi [République populaire de Chine] | Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry |
| 002993 (2009) |
Lanying Du [États-Unis] ; Yuxian He [États-Unis] ; Yusen Zhou [République populaire de Chine] ; Shuwen Liu [République populaire de Chine] ; Bo-Jian Zheng [République populaire de Chine] ; Shibo Jiang [États-Unis] | The spike protein of SARS-CoV — a target for vaccine and therapeutic development |
